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Summary.-Wistar rats were treated with a single dose of 30 mg/kg of
DMN or with single doses of 100, 200 or 300 mg/kg of EMS. Tumours of the kidney
developed in a few animals receiving EMS and in 33%o of the male and 63% of the
female rats treated with DMN alone. In the animals receiving DMN and, 8 hours
later, a single dose of 100, 200 or 300 mg/kg of EMS, an additive effect was observed
in the induction of kidney tumours. This additive effect was more pronounced
in female than in male rats. Morphologically, the tumours were of epithelial and
mesenchymal type with a preponderance of the former type. The significance
of alkylation of the nucleic acids of the kidney observed with these two compounds
is discussed in relation to the present findings.
A SINGLE dose of dimethylnitrosamine
(DMN), which is completely metabolized
within 5-6 hours, is sufficient to produce a
significant incidence of kidney tumours in
the rat (Magee and Barnes, 1959). Ethyl-
methanesulphonate (EMS) administered
in 3 large doses resulted in an increase of
lung adenomata and induced epithelial
cell tumours of the kidney in mice (Alex-
ander and Connell, 1963) and tumours of
the kidney in rats (Swann and Magee,
1969). Biochemical studies showed that
administration of a single dose of DMN or
EMS to rats results in the alkylation of
some cellular constituents of the kidney,
following metabolic activation in the case
of DMN and spontaneous breaking down
in the case of EMS (Swann and Magee,
1968, 1971).
Although the significance of alkylation
of cellular macromolecules in initiating a
carcinogenic process is not clear, it appears
that it is important for the carcinogenic
action of DMN and EMS. The induction
of kidney tumours after treatment with a
single dose of these two alkylating agents
is a promising model which allows a study
of the correlation between biological
response and biochemical interactions
with cellular components. The following
long-term studies were carried out in
order to examine a possible additive
effect in the induction of kidney tumours,
which might be the result of the total
level of alkylation of cellular components
after combined treatment with DMN and
EMS.
MATERIALS AND METHODS
The materials used were dimethylnitro-
samine (DMN), (obtained from Dr F. Kruger),
ethylmethanesulphonate (EMS), (T. Schuch-
ardt GmbH Co., Munich, Federal Republic of
Germany), and 0*9 0 sodium chloride.
Groups of Wistar rats of both sexes, 9-10
weeks old, from the colony of the Zentral
Institut fur Versuchstiersucht der Deutschen
Forschungsgemeinschaft, Hannover, were
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employed. All animals were observed and
weighed once weekly; they were killed 110
weeks after the treatment, by which time all
the animals of Group 7 had died spontan-
eously. Except for a few animals lost
through cannibalism, all were autopsied.
All the organs, including the central nervous
system, were examined macroscopically.
Eight graded histological sections were made
for each kidney and other pertinent tissues
were processed for histological examination.
Groups 1, 2 and 3 received a single i.p.
injection of 100, 200 and 300 mg/kg respec-
tively of EMS in 1 0 ml of 0.9% sodium
chloride. The solution of EMS was freshly
prepared beforetreatment. Group4received
a single i.p. injection of 30 mg/kg of DMN in
1 *0 ml of 0
-9% sodium chloride. The other
groups (Groups 5, 6 and 7) received a single
i.p. injection of DMN as in Group 4 and 8
hours later an i.p. injection of 100, 200 or
300 mg/kg of EMS respectively.
A control group received a single i.p.
injection of 1 0 ml of 0.9% sodium chloride.
The number of rats in each group is given in
Table I.
TABLE I.-Tumour Induction in Ratsfollowing Treatment with DMN and/or EMS
Groups
Control
1
EMS 100 mg
2
EMS 200 mg
3
EMS 300 mg
4
DMN 30 mg
5
DMN + EMS-100
6
DMN + EMS-200
7
DMN + EMS-300
Initial
no. of
animals
206
20 y
206
20 y
206'
20 y
206'
20 Y
19 d
21 y
206
20 y
256
20 y
356
40 y
Effective
no. of
animalsa
20
20
20
18
20
20
20
20
15
19
18
18
16
17
14
21
Total
tumour f bearing
animals Kidney
4
16
5
12
8
14
9
13
10
18
13
12
12
15
11
20
2
1
2
5
12
9
11
8
10
9
15
No. of animals with tumours of
Nasa Mamr
Nasal Mammary
cavities glands
9
9
1
13
1
8
3 1
5 6
4 1
2 4
2
6
2 2
6 2
Other
Lung organs
1
2
2
1
4
1
2
2
4b
Ic
3d
7e
7f
5g
7h
Si
5J
3k
71
6m
4n
80
7P
9q
a Survivors at time offirst tumour (11 weeks), less animals lost through cannibalism.
b 1 malignant lymphoma; 1 adrenal gland adenoma; 1 hepatoma; 1 tumour of the testis.
c 6 malignant lymphomata; 1 adrenal gland adenoma; 1 insuloma; 2 uterus carcinomata; 1 lipoma; 1
forestomach papilloma; 1 Zymbal gland squamous cell carcinoma.
d 1 malignant lymphoma; 1 adrenal gland adenoma; 1 fibrosarcoma of the heart; 1 intestinal adeno-
carcinoma.
e 2 malignant lymphomata; 2 uterus polyps; 1 squamous cell carcinoma ofthe vagina; 1 s.c. fibrosarcoma;
1 forestomach papilloma.
f 3 malignant lymphomata; 1 phaeochromocytoma; 1 lipoma; 1 hepatocellular carcinoma; 1 thyroid
carcinoma; 1 squamous cell carcinoma of the palate.
g 1 malignant lymphoma; 1 adrenal gland adenoma; 1 fibrosarcoma of the heart; 1 hepatoma; 1 fore-
stomach papilloma.
h 4 adrenal gland adenomata; 1 fibrosarcoma of the heart; 1 squarmous cell carcinoma of the palate; 1
carcinoma of the sebaceous glands; 2 papillomata of the tongue; 1 thyroid carcinoma.
i 2 malignant lymphomata; 5 fibrosarcomata of the heart; 1 granulosa cell carcinoma; 1 polyp of the
cervix; 1 luteoma; 1 bladder papilloma; 1 uterus haemangioma.
J 3 malignant lymphomata; 1 fibrosarcoma of the heart; 2 adrenal gland adenomata; 1 s.c. fibrosarcoma.
k 1 malignant lymphoma; 1 hepatoma; 1 intestinal haemangioma.
1 5 adrenal gland adenomata; 2 fibrosarcomata of the heart.
1nI malignantlyrmphoma; 1 adrenal glandadenoma; 1 thyroidcarcinoma; 1 adenocarcinoma ofthe ovary;
1 oesophageal papilloma; 1 insuloma.
n 2 adrenal glandadenomata; 1 fibrosarcoma of theheart; 1 thyroid carcinoma; 1 papillomaofthetongue.
° 4 malignant lymphomata; 3 adrenal gland adenomata; 1 squamous cell carcinoma of the palate; 1
intestinal sarcoma; 1 hepatoma; 1 osteosarcoma.
P 3 malignant lymphomata; 2 adrenal gland adeDomata; 1 fibrosarcoma of the heart; 1 hepatocellular
carcinoma; 1 hepatoma; 1 papilloma of the tongue.
q 5 malignant lymphomata; 2 adrenal gland adenomata; 1 fibrosarcoma of the heart; 1 hepatocellular
carcinoma; 1 forestomach papilloma; 1 luteoma; 1 papilloma of the tongue.
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RESULTS
During the first 10 weeks, no difference
in survival rates was observed between
control and treated groups, except; for
Groups 6 and 7 receiving the highest dose
of EMS in combination with DMN, where
a high mortality occurred within the first
week due to toxicity of the combined
treatment. Subsequently, a similar mor-
tality occurred among the rats of all
groups up to 60 weeks. From this time,
a greater mortality was noticed in Groups
6 and 7, due to the appearance oftumours.
Since all the animals of Group 7 were dead
by 110 weeks, we decided to sacrifice the
animals surviving among the other groups
as well at this time.
In the control groups, none of the
animals developed kidney tumours.
Tumours were found in 4 of the males;
they were a malignant lymphoma at 11
weeks, one adrenal cortical adenoma at
102 weeks, one hepatoma and a testicular
tumour at 110 weeks. Out of 20 females,
9 developed mammary gland tumours
and 6 had malignant lymphomata between
85 and 110 weeks. A few additional
tumours scattered in various organs,
developed after the 110 weeks (Table I).
Treatment with DMIN or EMS alone
The tumour incidences for all groups
are given in Table I. In Groups 1 and 3,
receiving a single dose of 100 or 300 mg/kg
of EMS, 5 out of 78 animals of both sexes
developed kidney tumours at an average
latent period ranging from 90 to 95 weeks.
No tumours of the kidney were observed
in Group 2. One rat of Group 3 showed a
lung tumour at 97 weeks. The incidence
of mammary gland tumours, malignant
lymphomata as well as other tumours was
similar to that observed in the control
group.
In Group 4, receiving a single dose of
30 mg/kg body weight of DMN, tumours
of the kidney developed in 3300 of the
males and in 6300 of the females, the
average time of appearance being 85-90
weeks. In addition, 8 rats developed
tumours of the nasal cavities and 2 out
of 34 tumours of the lung. Tumours of
other sites showed similar incidences to
those in the control group.
Combined Treatment with DMN and EMS
In Groups 5, 6 and 7 the final incidences
of kidney tumours were 50, 50 and 64%
in the males and 61, 59 and 710% in the
females respectively (Table I).
These data showed an increased
incidence of kidney tumours in the males
compared with the 33%0 incidence
observed in the males ofGroup 4 receiving
DMN alone. The females of Group 5
and 6 showed a similar final incidence of
kidney tumours to that ofGroup 4 (63%)0
whereas the highest tumour yield (71%)
was observed in Group 7, receiving the
highest dose of EMS in combination with
DMN.
Comparison of the percentage of
tumour incidences based on the initial
number of animals can be misleading if
deaths due to causes other than the
observed tumours occur at different rates
in the various experimental groups. For
this reason, the progression with time of
the cumulative probability for observing a
kidney tumour at death has been calcu-
lated by the actuarial method described
by Kaplan and Meier (1958). The
actuarial probabilities for observation of
kidney tumours at death in animals of
Groups 1, 3, 4, 5, 6 and 7 have been plotted
on Fig. 1, 2 and 3. When males and
females (Fig. 1) are examined together,
a considerable shortening of the latent
period for these tumours was observed in
therats receiving the combined treatments
when compared with rats receiving DMN
or EMS alone. However, some differ-
ences appear when males and females are
considered separately. In the females
(Fig. 2), all the rats receiving the combined
treatment show a shortening of the latent
period with no variation among these 3
groups, whereas in the males (Fig. 3) an
earlier appearance of kidney tumours
was confined to Group 7. Statistically,ADDITIVE EFFECT IN THE INDUCTION OF KIDNEY TUMOURS
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FIG. 1.-Probability for the observation of a kidney tumour in male and female rats at
death, calculated according to Kaplan and Meier (1958). 0 O, Group 1; ----- 0, Group
3; *- 0*, Group 4; x x, Group 5; x--- - x, Group 6; +----+, Group 7. No kidney
tumours were observed in Group 2.
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FiG. 2.-Probability for the observation of a kidney tumour in female rats at death, calculated
according to Kaplan and Meier (1958). * *, Group 4; x x, Group 5; x- x,
Group 6; + +, Group 7. One kidney tumour was observed in a rat of Group 1 at 89 weeks.
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Fin. 3. Probability for the observation of a kidney tumour in male rats at death, calculated accord-
ing to Kaplan and Meier (1958). * *, Group 4; x- x, Group 5; x ---- x, Group 6;
+-.-.+, Group 7. Two kidney tumours were observed in rats ofGroup 1 and Group 3 respectively,
dying between 88 and 96 weeks.
the greater incidence of kidney tumours
observed in female and male rats of
Group 7 was highly significant when
compared with the rats of Group 4, as
shown in Table III, where the instan-
taneous tumour mortality rates and the
associated x2 values relative to the DMN
alone treated rats for the 3 groups receiv-
ing the combined DMN plus EMS treat-
ment were calculated according to Mantel
(1966). The rats of Groups 5 and 6
showed a tendency to a greater tumour
mortality but these results failed to
obtain a statistical significance with the
exception of borderline values for the
females of Group 5.
TABLE II. Multiplicity of Tumours Induced in Rats by DMJIN and/or EMS
Total Total no.
Group tumour bearing animals of tumours Ratio
Control c 4 4 10 *
16 23 1 43
1 5 6 1-20
12 17 1 41
2 d 8 9 1-12
14 19 1-35
3 9 15 1-66
13 22 1 69
4 10 19 1 90
OY 18 47 2-61
5 CT 13 33 2 - 53
12 34 2 * 83
6 12 32 2- 66
15 41 2- 73
7 .I 40 3-63
20 64 3 * 20
I1.0
$A
-
4
z
£
0
a
01
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1FIG. 4.-Large mesenchymal tumour of the kidney.
Group 5. x 1* 5.
FIG. 6. Part of a kidney adenoma demonstrating
expansive growth. Group 5. H. & E. x 120.
FIG. 5.-Bilateral and multiple adenocarcinomata
of the kidney. Group 7. x 1 5.
FIG. 7. Mesenchymal tumour of the kidney.
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TABLE III.-Instantaneous Kidney Tumour Mortality Rates Relative to DMN Alone
(RR), and Associated x2 Values, for the Three Groups treated with DMN plus EMS,
by Sex (Mantel, 1966)
Sex DMN + 100 mg EMS
RR X2 P
Y + d 0 4381 4 06 <0*05
y 0- 3201 3 8668 <0*05
d 006069 0-267 , 0*60
DMN + 200 mg EMS
RR X2 P
0-5912 1*6461 0*20
0-4178 2*2888 -.0*13
0 6114 0*3156 .0*57
DMN + 200 mg EMS
RR X2 P
0-2448 15-9863 <0*0001
0 2885 7 3636 <0*01 0-1767 6 6659 <0 01
Among the other types of tumours, no
differences were observed between these
groups and the DMN-alone treated group,
with the possible exception of lung
tumours which occur in a slightly higher
number.
Another indication of the additive
effect of EMS and DMN in their carcino-
genic action is given by the multiplicity of
tumours induced. As shown in Table II,
the ratio of the total number of tumours
over the total tumour bearing animals
markedly increases in the groups treated
with DMN plus EMS.
Morphology
The morphological aspects of the
kidney tumours reported here were
analogous to those previously described
by various authors (Magee and Barnes,
1962; Hard and Butler, 1970; Riopelle
and Jasmnin, 1969). They were of 2
histological types epithelial (Fig. 6) and
mesenchymal (Fig. 7), which developed
as multiple growths localized in the
cortical region (Fig. 5). The mesen-
chymal tumours appeared as large growths
with a tendency to necrosis and haemorr-
hage (Fig. 4). Occasionally metastases
were observed in the lung. A preponder-
ance of adenomata and/or adenocarcino-
mata over mesenchymal tumours was
observed in all the groups. In the
EMS-alone treated rats (Groups 1 and 3)
bearing a total of 5 kidney tumours, 3
were epithelial and 2 mesenchymal. In
the other groups, 90% of the kidney
tumours were of the epithelial type. No
differences were detected among females
and males on the tumour type.
The tumours of the nasal cavities were
of various types, such as squamous cell
papillomata and carcinomata, adenomata,
adenocarcinomata and undifferentiated
carcinomata. The lung tumours were 8
adenomata, 4 adenocarcinomata and 3
squamous cell carcinomata.
DISCUSSION
The present studies show an additive
effect in the induction of kidney tumours
in rats following combined treatment with
single doses of EMS and DMN. In
addition, the carcinogenicity of EMS has
been confirmed.
Previous studies (Swann and Magee,
1969) in female Wistar rats showed that
3 doses of 275 mg/kg of EMS adminis-
tered over a period of a week were
necessary to induce mesenchymal kidney
tumours in 50% of the rats, whereas
after a single dose of 350 mg/kg, a brain
tumour was observed but no kidney
tumours. Our results show that a single
dose of 100 or 300 mg/kg is sufficient to
induce a low incidence of kidney tumours
in these rats after a latent period of
90-95 weeks. The fact that no kidney
tumours were observed in the studies of
Hrushesky, Sampson and Murphy (1972)
might be attributed to the early sacrifice
of the animals. The rats, treated with
DMN alone (Group 4), showed an incidence
of 33% of kidney tumours in the males
which is comparable with previous data
(McLean and Magee, 1970; Schmidt and
Murphy, 1966). The final yield of kidney
tumours in females reached an incidence
of 63%. A high susceptibility of the
females has been previously reported in
Wistar and Sprague-Dawley rats (Magee
and Barnes, 1962; Riopelle and Jasmin,
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The additive effect between EMS and
DMN in the induction of kidney tumours
is more pronounced in the female rats
(Fig. 2), where a higher tumour yield is
present in all DMN plus EMS treated
groups than in males (Fig. 3) where this
effect is confined to the group receiving
the highest dose of EMS combined with
DMN. The higher multiplicity of
tumours as well as the number of lung
tumours in rats receiving the combined
treatment (Table I and II) suggest that
the carcinogenic additive effect is not
confined to the kidney but is present to a
lesser extent in other organs as well.
The induction of kidney tumours in
rats treated with a single dose of various
alkylating agents has already been
exploited to correlate quantitatively the
levels of alkylation in this organ and the
tumour yield. Swann and Magee (1968,
1971) examined the amount of alkylation
in kidney nucleic acids by dimethylnitro-
samine, N-nitroso-N-methylurea, methyl-
methanesulphonate and the corresponding
ethyl derivatives and they found a lack
of correlation between the amount of
alkylation of N-7 in guanine residues by
each compound and their carcinogenic
activity. In particular, the extent of
conversion of guanine to 7-methylguanine
was closely similar in the kidneys with
dimethylnitrosamine and nitrosomethyl-
urea, both of which induce tumours in
this organ. With methylmethane-
sulphonate, however, the yield of 7-
methylguanine in the kidney nucleic acids
was of the same order as that found with
the 2 nitroso compounds, but no kidney
tumours were observed in the rats surviv-
ing a single dose ofthis compound. Simi-
lar results were obtained with the corres-
ponding ethylating agents, among which a
single dose of 270 mg/kg ofEMS produced
5-10 times more 7-ethylguanine in rat
kidney DNA than a carcinogenic dose of
diethylnitrosamine or ethylnitrosourea.
In these studies, a dose as large as 350
mg/kg body weight of EMS failed to
induce kidney tumours; in the present
studies, however, a single dose of 100
mg/kg body weight was sufficient to
induce a low incidence of kidney tumours.
However, these experiments (Swann and
Magee, 1968, 1971) compared only the
extent of alkylation of N-7 of guanine
residues, which is the major alkylation
site in nucleic acid bases, by these com-
pounds. The question whether other
alkylated sites in nucleic acids may be
more important in the initiation of the
carcinogenic process has been reviewed
by Lawley (1972). As originally sug-
gested by Loveless (1969) and sub-
stantiated by Gerchman and Ludlum
(1973), alkylation of the 0-6 atom of
guanine can cause mispairing of bases
and thus induce transition mutations.
O'Connor, Capps and Craig (1973) have
shown that O-6-methylguanine is present
in hepatic DNA from rats treated with
DMN, but none was detected after treat-
ment of the animals with methyl-
methanesulphonate. EMS is known to
react in vitro to the 0-6 position of
guanine residues of DNA (Lawley, 1972).
The additive effect in the induction
of kidney tumours in rats by a single
dose of DMN and EMS, demonstrated
in these studies, suggests that it might
be the result of the total nucleic acid
alkylation by these two compounds.
However, which specific site(s) of alky-
lated nucleic acid bases is (are) involved
in initiating the carcinogenic process
remains to be established. Another fac-
tor, that could be related to the present
findings is the impairment by the EMS of
the cellular immune response which is
known to occur with various alkylating
agents (Kruger, 1972).
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